Skip to content

Sensory Stimulation During Simulated Driving

Sensory-based Stimulation to Increase Alertness and Behavioral Performance During Simulated Driving

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03726840
Enrollment
75
Registered
2018-11-01
Start date
2018-10-08
Completion date
2019-06-30
Last updated
2020-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior

Brief summary

The purpose of this study is to examine the effect of three specific odors on simulated driving performance. It is hypothesized that the presence of peppermint, rosemary, and zest/pulp will increase memory recall for navigation and improve reaction times for braking, compared to performance during unscented conditions

Detailed description

This study will examine the effect of scented odors on the attention and behavioral performance of healthy young adult and older adult drivers. Past research indicates that specific scented odors (i.e., peppermint and cinnamon) enhance motivation, performance and alertness, decrease fatigue and stimulate the central nervous system in a variety of contexts. The current study will examine the effect of three different odors on simulated driving as participants perform navigation and braking scenarios. This study will be the first of its kind to elucidate the association between specific scents and performance gains in simulated driving. The data will serve as proof-of-concept for eventual patient focused interventions relative to sensory stimulation and driving.

Interventions

peppermint, rosemary, and zest/pulp will increase memory recall for navigation and improve reaction times for braking, compared to performance during unscented conditions

Sponsors

Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
24 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* valid drivers license * normal or corrected to normal vision

Exclusion criteria

* no drivers license * hyperopic vision without contact lenses * history of congenital or acquired cognitive, ophthalmologic, or neurological disorders including developmental delay, brain tumor, stroke, or known peripheral or central vestibular disorders * participants who have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) will be excluded * Participants will also be excluded if they have: (a) a history of skin irritation or sensitivity to scented products or cosmetics, (b) known skin allergies, sensitive skin or allergies to fragrance, (c) suffers from a cold, allergy, sinus condition or any other condition that might interfere with their sense of smell and (d) is pregnant or nursing. * Participants will also be excluded if they smoke or use tobacco related products * participants will be excluded if they commonly experience motion sickness

Design outcomes

Primary

MeasureTime frameDescription
Navigation Assessment30 minutesThe navigation task will consist of up to six blocks of instruction/recall segments that will contain the same number of turns over the same distance, but with novel environmental stimuli and a randomized order of turns unique to each block.

Secondary

MeasureTime frameDescription
Braking Assessment15 minutesa virtual stop sign will appear suddenly in the middle of the visual field. The participant will be instructed to come to a stop as quickly as possible and to remain stopped until the stop sign disappears
Workload and mood assessment5 minutesparticipants will be asked to rank their perceived mental, physical, and temporal demands in combination with their performance, effort and frustration
Scent assessment5 minutesA short fragrance questionnaire will be given after each study session, in order to ensure that participants are able to distinguish between non-scented and scented conditions

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026